RapidAI (formerly iSchemaView)
About RapidAI (formerly iSchemaView)
RapidAI, formerly known as iSchemaView, is a leading healthcare AI company that develops a clinical AI platform designed to enhance medical imaging and improve patient care, particularly for life-threatening neurovascular, cardiac, and vascular diseases. The company’s core technology, the Rapid Enterprise™ Platform, utilizes deep clinical AI to go beyond simple anomaly detection, providing comprehensive insights by measuring, localizing, visualizing, and characterizing diseases, and tracking changes over time.
For physicians, RapidAI’s platform offers a suite of tools that integrate seamlessly into existing workflows, connecting radiology, specialists, and care teams for faster, more confident decision-making. This includes solutions for neurovascular conditions like ischemic stroke, hemorrhagic stroke, and aneurysms, as well as cardiac and vascular analysis, and radiology workflows. The platform aims to reduce cognitive burden, streamline care coordination, and ultimately improve patient outcomes by delivering real-time, actionable intelligence from medical images. RapidAI’s technology has been deployed in over 2,200 hospitals in more than 100 countries and is supported by extensive clinical validation, including over 700 studies.
Focus Areas
Business Intelligence
| Technology | Rapid Enterprise™ Platform, Rapid Edge Cloud (hybrid infrastructure with cloud and on-prem capabilities), deep clinical AI, static algorithms |
What Physicians Need to Know
RapidAI's deep clinical AI goes beyond simple detection and notification, offering detailed insights such as precise location, volume, size of anomalies, and even salvageable tissue. Physicians can expect faster, more confident decision-making due to real-time, patient-specific insights and advanced 3D visualization. The mobile app and integrated workflows facilitate seamless communication and collaboration among care teams, reducing delays in treatment. For radiologists, Navigator Pro streamlines interaction with AI output directly within their PACS workflow, minimizing context switching and cognitive burden. The platform also provides data and analytics for performance visibility, utilization, and clinical impact, aiding in optimizing outcomes.
RapidAI's platform is designed for secure, vendor-agnostic integration with existing hospital IT systems, including PACS and EHRs, to ensure minimal disruption and seamless interoperability. It also supports the integration of curated third-party AI modules, expanding clinical coverage across specialties without adding disconnected workflows or infrastructure.
What the Web Says
RapidAI, formerly iSchemaView, is a company specializing in AI-driven medical imaging solutions for stroke, trauma, and vascular conditions. Their platform analyzes brain and vascular scans to expedite diagnosis and treatment decisions, with a strong focus on stroke care. While the product is generally well-regarded for its clinical efficacy and speed, employer reviews indicate significant issues with company culture and management. The mobile app has also received criticism for glitches and login problems.
Overall: MixedStrengths
- Clinically superior product for stroke detection and treatment outcomes.
- Expedites diagnosis and treatment decisions for life-threatening conditions.
- Offers flexibility for remote work for some positions.
- Strong record in published stroke trials, influencing treatment guidelines.
- Integrates with hospital systems via PACS and mobile apps.
- Provides comprehensive benefits for employees.
Limitations
- Highly negative employer reviews citing toxic executive team, mental abuse, and micro-management.
- Poor pay and benefits, and limited job security and advancement opportunities according to some employees.
- Mobile app experiences frequent glitches, login issues, and unreliable notifications.
- Cost-effectiveness of the product is currently unknown.
- Lack of transparency regarding machine-learning model development and potential for bias.
- Some radiologists find AI tools, including LVO detection, to be unhelpful or generate too many false positives/negatives.
Based on reviews from: Indeed.com, Healthcare Industry Reviews, Elion Health, SourceForge, Reddit, NCBI Bookshelf, Canada's Drug Agency, ResearchGate, G2, Apple App Store, Google Play Store, Working Nomads, Slashdot
Last updated: 2026-10-25
Videos
News, demos, and interviews about RapidAI (formerly iSchemaView).
Videos load interactively. If none appear, search YouTube for RapidAI (formerly iSchemaView) →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]